Beximco Pharmaceuticals PLC. (BST:R2WA)
Germany flag Germany · Delayed Price · Currency is EUR
0.4760
+0.0100 (2.15%)
At close: Feb 5, 2026

BST:R2WA Balance Sheet

Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20
Cash & Equivalents
1,655854.111,1361,169675.47635.02
Short-Term Investments
1,197369.37166.25108.07112.8370.79
Cash & Short-Term Investments
2,8521,2231,3021,277788.3705.81
Cash Growth
64.65%-6.03%1.97%61.96%11.69%-28.85%
Accounts Receivable
4,0473,4623,3702,9632,7263,089
Other Receivables
-304.98215.62217.35174.05223.58
Receivables
4,0473,7673,5863,1802,9003,312
Inventory
15,19013,30713,47311,5738,2657,163
Prepaid Expenses
-136.6260.9653.2336.03155.35
Other Current Assets
2,5432,3832,4552,3351,7811,713
Total Current Assets
24,63220,81820,87618,41913,77113,049
Property, Plant & Equipment
43,69443,04942,80842,21236,53135,241
Long-Term Investments
20.9720.9720.9723.3616.593.75
Goodwill
674.57674.57674.57674.57546.69546.69
Other Intangible Assets
4,7224,7214,7214,7301,3811,276
Long-Term Deferred Tax Assets
57.8860.8956.5188.64--
Total Assets
73,80269,34469,15766,14852,24650,119
Accounts Payable
3,3031,4021,6181,373769.2575.01
Accrued Expenses
1,3432,8322,5812,0421,4201,466
Short-Term Debt
3,0602,9976,6216,8515,0237,398
Current Portion of Long-Term Debt
983.931,1321,2931,9051,2871,346
Current Portion of Leases
124.47139.3146.52160.58113.98108.12
Current Income Taxes Payable
828.95429.27454.0999.45222.51285.89
Current Unearned Revenue
-80.24149.41110.41298.412.39
Other Current Liabilities
1,895551.38401.5193.85214.81165.61
Total Current Liabilities
11,5399,56213,26512,7369,35011,358
Long-Term Debt
1,7661,4332,1582,997972.71,443
Long-Term Leases
258.7324.72393.12456.76234.02208.86
Pension & Post-Retirement Benefits
4,0462,1041,8761,6241,3221,186
Long-Term Deferred Tax Liabilities
2,5642,5752,5502,5371,9902,168
Other Long-Term Liabilities
-1,4431,2951,1611,013958.38
Total Liabilities
20,17317,44121,53721,51214,88117,321
Common Stock
4,4614,4614,4614,4614,4614,056
Additional Paid-In Capital
6,9596,9596,9596,9596,9596,959
Retained Earnings
36,80735,07930,80627,74824,18020,059
Comprehensive Income & Other
1,4491,4501,4541,4321,4311,422
Total Common Equity
49,67647,95043,68140,60037,03132,495
Minority Interest
3,9533,9533,9394,036334.31302.33
Shareholders' Equity
53,62951,90347,62044,63637,36532,797
Total Liabilities & Equity
73,80269,34469,15766,14852,24650,119
Total Debt
6,1936,02510,61212,3717,63110,504
Net Cash (Debt)
-3,341-4,802-9,310-11,094-6,843-9,798
Net Cash Per Share
-7.49-10.76-20.87-24.87-15.34-21.96
Filing Date Shares Outstanding
446.11446.11446.11446.11446.11446.11
Total Common Shares Outstanding
446.11446.11446.11446.11446.11446.11
Working Capital
13,09311,2567,6115,6834,4211,691
Book Value Per Share
111.35107.4897.9191.0183.0172.84
Tangible Book Value
44,27942,55538,28535,19635,10330,673
Tangible Book Value Per Share
99.2695.3985.8278.9078.6968.76
Land
7,8927,8927,892-4,0684,068
Buildings
17,04617,00516,704-8,1297,822
Machinery
33,20433,21931,733-18,66317,542
Construction In Progress
3,2961,9381,847-16,50715,789
Source: S&P Global Market Intelligence. Standard template. Financial Sources.